Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Tandem Mass Spectrometry | 13 | 2024 | 1197 | 2.050 |
Why?
|
Chromatography, High Pressure Liquid | 8 | 2024 | 1534 | 1.560 |
Why?
|
Chromatography, Liquid | 10 | 2024 | 996 | 1.380 |
Why?
|
Busulfan | 3 | 2020 | 259 | 0.900 |
Why?
|
Hyperammonemia | 3 | 2013 | 80 | 0.880 |
Why?
|
Immunoassay | 8 | 2021 | 746 | 0.860 |
Why?
|
Hypokalemia | 1 | 2023 | 152 | 0.810 |
Why?
|
Blood Chemical Analysis | 3 | 2013 | 435 | 0.740 |
Why?
|
Hemolysis | 2 | 2023 | 417 | 0.720 |
Why?
|
Chemistry, Clinical | 2 | 2015 | 64 | 0.710 |
Why?
|
Caffeine | 4 | 2013 | 703 | 0.680 |
Why?
|
Saxitoxin | 2 | 2016 | 65 | 0.660 |
Why?
|
Jaundice | 1 | 2018 | 95 | 0.600 |
Why?
|
Alcoholic Intoxication | 1 | 2018 | 171 | 0.580 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 3 | 2022 | 267 | 0.570 |
Why?
|
Amino Acids | 4 | 2013 | 1716 | 0.550 |
Why?
|
Cotinine | 4 | 2015 | 206 | 0.520 |
Why?
|
Anticonvulsants | 3 | 2024 | 1923 | 0.510 |
Why?
|
Neuromuscular Blocking Agents | 1 | 2016 | 132 | 0.500 |
Why?
|
Lead Poisoning | 2 | 2024 | 323 | 0.480 |
Why?
|
Acetaminophen | 1 | 2018 | 552 | 0.460 |
Why?
|
25-Hydroxyvitamin D 2 | 2 | 2020 | 40 | 0.460 |
Why?
|
Theobromine | 2 | 2013 | 14 | 0.450 |
Why?
|
Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2013 | 23 | 0.450 |
Why?
|
gamma-Glutamyl Hydrolase | 2 | 2010 | 8 | 0.440 |
Why?
|
Hyperlipidemias | 1 | 2018 | 772 | 0.440 |
Why?
|
Methotrexate | 2 | 2010 | 1721 | 0.430 |
Why?
|
Hyperargininemia | 1 | 2012 | 12 | 0.420 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2014 | 219 | 0.390 |
Why?
|
Information Services | 1 | 2013 | 239 | 0.390 |
Why?
|
Argininosuccinic Aciduria | 1 | 2011 | 11 | 0.380 |
Why?
|
Resistance Training | 4 | 2018 | 198 | 0.380 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 677 | 0.380 |
Why?
|
Confusion | 1 | 2013 | 278 | 0.370 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2011 | 72 | 0.370 |
Why?
|
Anesthetics | 1 | 2016 | 525 | 0.360 |
Why?
|
Lead | 3 | 2024 | 882 | 0.360 |
Why?
|
Drug Discovery | 2 | 2019 | 1068 | 0.350 |
Why?
|
Metabolism, Inborn Errors | 2 | 2024 | 292 | 0.350 |
Why?
|
Access to Information | 1 | 2013 | 317 | 0.340 |
Why?
|
Wine | 1 | 2010 | 172 | 0.340 |
Why?
|
Bioterrorism | 2 | 2009 | 144 | 0.340 |
Why?
|
Saliva | 3 | 2014 | 853 | 0.330 |
Why?
|
Food Contamination | 1 | 2010 | 193 | 0.320 |
Why?
|
Tryptophan | 1 | 2011 | 482 | 0.320 |
Why?
|
Cacao | 1 | 2009 | 98 | 0.310 |
Why?
|
Nephelometry and Turbidimetry | 1 | 2008 | 91 | 0.310 |
Why?
|
Affect | 4 | 2013 | 1495 | 0.310 |
Why?
|
Epilepsy | 1 | 2024 | 3327 | 0.300 |
Why?
|
Antibodies, Heterophile | 1 | 2008 | 128 | 0.300 |
Why?
|
Goiter | 1 | 2008 | 86 | 0.300 |
Why?
|
Health Services | 1 | 2013 | 755 | 0.290 |
Why?
|
Iodide Peroxidase | 2 | 2023 | 295 | 0.290 |
Why?
|
Diabetic Ketoacidosis | 1 | 2011 | 257 | 0.290 |
Why?
|
Drug Industry | 1 | 2014 | 791 | 0.290 |
Why?
|
Drug Monitoring | 3 | 2024 | 964 | 0.280 |
Why?
|
Cystatin C | 1 | 2008 | 272 | 0.280 |
Why?
|
Antimetabolites, Antineoplastic | 1 | 2010 | 646 | 0.270 |
Why?
|
Dehydration | 2 | 2005 | 216 | 0.270 |
Why?
|
Galactosemias | 3 | 2014 | 126 | 0.270 |
Why?
|
Antineoplastic Agents, Alkylating | 1 | 2010 | 614 | 0.270 |
Why?
|
Artifacts | 2 | 2012 | 1926 | 0.260 |
Why?
|
Interleukin-1beta | 1 | 2012 | 1027 | 0.260 |
Why?
|
Reproducibility of Results | 13 | 2024 | 20227 | 0.260 |
Why?
|
Jewelry | 1 | 2024 | 4 | 0.240 |
Why?
|
Chemistry Techniques, Analytical | 1 | 2005 | 49 | 0.240 |
Why?
|
Osteosarcoma | 1 | 2010 | 911 | 0.240 |
Why?
|
Thyrotropin | 1 | 2008 | 834 | 0.240 |
Why?
|
Information Dissemination | 1 | 2013 | 1143 | 0.230 |
Why?
|
Putrescine | 1 | 2024 | 42 | 0.230 |
Why?
|
Water-Electrolyte Balance | 1 | 2005 | 326 | 0.230 |
Why?
|
Body Water | 1 | 2005 | 340 | 0.230 |
Why?
|
Limit of Detection | 3 | 2016 | 277 | 0.220 |
Why?
|
Interferon-gamma | 1 | 2012 | 3160 | 0.220 |
Why?
|
Metabolomics | 2 | 2024 | 1674 | 0.210 |
Why?
|
Vitamin D | 2 | 2017 | 3311 | 0.210 |
Why?
|
Interleukin-6 | 2 | 2014 | 3228 | 0.210 |
Why?
|
False Positive Reactions | 2 | 2018 | 963 | 0.210 |
Why?
|
Humans | 80 | 2024 | 768166 | 0.200 |
Why?
|
Phlebotomy | 1 | 2023 | 138 | 0.200 |
Why?
|
Pyomyositis | 1 | 2022 | 10 | 0.200 |
Why?
|
Tobacco Smoke Pollution | 4 | 2015 | 828 | 0.200 |
Why?
|
Hodgkin Disease | 1 | 2010 | 1384 | 0.200 |
Why?
|
Thiocyanates | 1 | 2022 | 70 | 0.200 |
Why?
|
Chromatography, Ion Exchange | 2 | 2013 | 293 | 0.200 |
Why?
|
Milk Proteins | 2 | 2013 | 161 | 0.190 |
Why?
|
Central Nervous System Stimulants | 2 | 2013 | 1168 | 0.190 |
Why?
|
Human Growth Hormone | 2 | 2018 | 651 | 0.190 |
Why?
|
Homocysteine | 1 | 2005 | 637 | 0.190 |
Why?
|
Calibration | 3 | 2021 | 819 | 0.190 |
Why?
|
Neural Cell Adhesion Molecules | 1 | 2021 | 122 | 0.180 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 4352 | 0.180 |
Why?
|
UTP-Hexose-1-Phosphate Uridylyltransferase | 2 | 2010 | 68 | 0.170 |
Why?
|
High-Throughput Screening Assays | 2 | 2019 | 942 | 0.170 |
Why?
|
Acidosis | 1 | 2022 | 271 | 0.170 |
Why?
|
Attention | 3 | 2013 | 2424 | 0.170 |
Why?
|
Baths | 1 | 2019 | 52 | 0.170 |
Why?
|
Sweetening Agents | 2 | 2012 | 290 | 0.160 |
Why?
|
Dietary Supplements | 4 | 2016 | 3445 | 0.160 |
Why?
|
Choice Behavior | 1 | 2005 | 848 | 0.160 |
Why?
|
Reference Standards | 4 | 2024 | 1014 | 0.160 |
Why?
|
Skin Diseases, Bacterial | 1 | 2019 | 65 | 0.160 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2019 | 61 | 0.160 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8054 | 0.160 |
Why?
|
Gastrointestinal Hormones | 1 | 2019 | 101 | 0.160 |
Why?
|
Erythrocyte Count | 1 | 2019 | 157 | 0.150 |
Why?
|
Exercise | 5 | 2018 | 5955 | 0.150 |
Why?
|
Gas Chromatography-Mass Spectrometry | 2 | 2017 | 354 | 0.150 |
Why?
|
Arthritis, Infectious | 1 | 2022 | 348 | 0.150 |
Why?
|
Beverages | 3 | 2013 | 819 | 0.150 |
Why?
|
Hemoglobins | 2 | 2019 | 1531 | 0.150 |
Why?
|
Chlorhexidine | 1 | 2019 | 159 | 0.150 |
Why?
|
Acute Kidney Injury | 1 | 2010 | 1942 | 0.150 |
Why?
|
Bone Neoplasms | 1 | 2010 | 2565 | 0.150 |
Why?
|
Energy Intake | 3 | 2014 | 2146 | 0.150 |
Why?
|
Erythrocyte Indices | 1 | 2019 | 143 | 0.150 |
Why?
|
Osteomyelitis | 1 | 2022 | 408 | 0.150 |
Why?
|
Seizures | 1 | 2011 | 2998 | 0.150 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2017 | 3814 | 0.150 |
Why?
|
Osmolar Concentration | 1 | 2018 | 657 | 0.150 |
Why?
|
Body Composition | 6 | 2011 | 2462 | 0.140 |
Why?
|
Cyanosis | 1 | 2017 | 82 | 0.140 |
Why?
|
Hematocrit | 1 | 2019 | 623 | 0.140 |
Why?
|
Prostatic Hyperplasia | 1 | 2021 | 516 | 0.140 |
Why?
|
Anti-Infective Agents, Local | 1 | 2019 | 247 | 0.140 |
Why?
|
Caloric Restriction | 2 | 2011 | 301 | 0.140 |
Why?
|
Ginkgo biloba | 1 | 2016 | 26 | 0.140 |
Why?
|
Hormones | 1 | 2021 | 866 | 0.140 |
Why?
|
Citrulline | 2 | 2014 | 107 | 0.140 |
Why?
|
Adolescent | 16 | 2022 | 89169 | 0.140 |
Why?
|
Diapers, Infant | 1 | 2016 | 3 | 0.140 |
Why?
|
Patients | 1 | 2023 | 908 | 0.140 |
Why?
|
Visual Perception | 1 | 2005 | 1402 | 0.140 |
Why?
|
Solid Phase Extraction | 1 | 2016 | 28 | 0.140 |
Why?
|
Vitamin A | 1 | 2020 | 611 | 0.140 |
Why?
|
Oxyhemoglobins | 1 | 2017 | 213 | 0.140 |
Why?
|
Milk, Human | 1 | 2021 | 490 | 0.130 |
Why?
|
Male | 42 | 2024 | 364719 | 0.130 |
Why?
|
Disulfides | 1 | 2018 | 466 | 0.130 |
Why?
|
Catheter-Related Infections | 1 | 2019 | 275 | 0.130 |
Why?
|
Blood Gas Analysis | 1 | 2017 | 384 | 0.130 |
Why?
|
Cannabinoids | 1 | 2018 | 174 | 0.130 |
Why?
|
Flagellin | 1 | 2017 | 124 | 0.130 |
Why?
|
Musculoskeletal Diseases | 1 | 2022 | 599 | 0.130 |
Why?
|
Medicine, Traditional | 1 | 2016 | 89 | 0.130 |
Why?
|
Lyme Disease | 1 | 2022 | 630 | 0.130 |
Why?
|
Military Personnel | 5 | 2011 | 1261 | 0.130 |
Why?
|
Vitamin E | 1 | 2020 | 874 | 0.120 |
Why?
|
Genetic Diseases, Inborn | 1 | 2020 | 606 | 0.120 |
Why?
|
Delivery of Health Care | 1 | 2013 | 5367 | 0.120 |
Why?
|
Infant | 12 | 2024 | 36535 | 0.120 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2016 | 162 | 0.120 |
Why?
|
UDPglucose 4-Epimerase | 1 | 2014 | 14 | 0.120 |
Why?
|
Oximetry | 1 | 2017 | 462 | 0.120 |
Why?
|
Eating | 1 | 2021 | 1542 | 0.110 |
Why?
|
Autoantibodies | 1 | 2023 | 2121 | 0.110 |
Why?
|
Insulin-Like Growth Factor I | 3 | 2008 | 1942 | 0.110 |
Why?
|
Nutrition Surveys | 2 | 2019 | 1738 | 0.110 |
Why?
|
Muscle Strength | 1 | 2018 | 640 | 0.110 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2019 | 1151 | 0.110 |
Why?
|
Double-Blind Method | 9 | 2015 | 12465 | 0.110 |
Why?
|
Dehydroepiandrosterone Sulfate | 2 | 2011 | 241 | 0.110 |
Why?
|
Anesthesia, Local | 1 | 2015 | 278 | 0.110 |
Why?
|
Mitochondrial Proteins | 1 | 2019 | 979 | 0.110 |
Why?
|
Enteral Nutrition | 1 | 2019 | 802 | 0.110 |
Why?
|
Plant Extracts | 1 | 2016 | 497 | 0.110 |
Why?
|
Mucositis | 1 | 2014 | 108 | 0.110 |
Why?
|
Immunoglobulin A | 1 | 2017 | 992 | 0.110 |
Why?
|
Protein Hydrolysates | 1 | 2012 | 7 | 0.100 |
Why?
|
Malabsorption Syndromes | 1 | 2013 | 135 | 0.100 |
Why?
|
Liver Regeneration | 1 | 2014 | 214 | 0.100 |
Why?
|
Enzyme Assays | 2 | 2010 | 103 | 0.100 |
Why?
|
Specimen Handling | 2 | 2023 | 708 | 0.100 |
Why?
|
Bupivacaine | 1 | 2015 | 414 | 0.100 |
Why?
|
Epinephrine | 1 | 2015 | 794 | 0.100 |
Why?
|
Laboratories | 2 | 2020 | 463 | 0.100 |
Why?
|
Growth Disorders | 1 | 2017 | 635 | 0.100 |
Why?
|
Ammonia | 1 | 2012 | 247 | 0.090 |
Why?
|
Mouth Mucosa | 1 | 2014 | 435 | 0.090 |
Why?
|
Satiety Response | 1 | 2011 | 47 | 0.090 |
Why?
|
Alcohol Drinking | 2 | 2016 | 4045 | 0.090 |
Why?
|
Galactokinase | 1 | 2010 | 18 | 0.090 |
Why?
|
Bumetanide | 1 | 2011 | 101 | 0.090 |
Why?
|
Appetite Regulation | 1 | 2011 | 84 | 0.090 |
Why?
|
Reference Values | 4 | 2019 | 4938 | 0.090 |
Why?
|
Reaction Time | 2 | 2008 | 2101 | 0.090 |
Why?
|
Cross Infection | 1 | 2019 | 1426 | 0.090 |
Why?
|
Food Deprivation | 2 | 2008 | 114 | 0.090 |
Why?
|
Urea | 1 | 2012 | 448 | 0.090 |
Why?
|
Diarrhea | 1 | 2017 | 1320 | 0.080 |
Why?
|
Parkinson Disease | 1 | 2024 | 2893 | 0.080 |
Why?
|
Liver | 2 | 2016 | 7577 | 0.080 |
Why?
|
Xanthines | 1 | 2009 | 121 | 0.080 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2011 | 505 | 0.080 |
Why?
|
Kidney | 1 | 2005 | 7064 | 0.080 |
Why?
|
Gastrointestinal Diseases | 1 | 2018 | 1206 | 0.080 |
Why?
|
Adrenal Hyperplasia, Congenital | 1 | 2010 | 98 | 0.080 |
Why?
|
Antimicrobial Cationic Peptides | 1 | 2011 | 352 | 0.080 |
Why?
|
Child Development | 1 | 2021 | 2330 | 0.080 |
Why?
|
Zinc | 1 | 2013 | 677 | 0.080 |
Why?
|
Vulnerable Populations | 1 | 2015 | 718 | 0.080 |
Why?
|
Ghrelin | 1 | 2011 | 251 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2219 | 0.080 |
Why?
|
Immunochemistry | 1 | 2008 | 116 | 0.080 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 1 | 2009 | 126 | 0.080 |
Why?
|
Leptin | 2 | 2021 | 1599 | 0.080 |
Why?
|
Anthrax | 1 | 2009 | 83 | 0.080 |
Why?
|
Biochemical Phenomena | 1 | 2008 | 59 | 0.080 |
Why?
|
Sleep | 2 | 2018 | 4819 | 0.080 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2009 | 238 | 0.080 |
Why?
|
Anemia, Sideroblastic | 1 | 2009 | 106 | 0.080 |
Why?
|
Motor Activity | 2 | 2008 | 2711 | 0.080 |
Why?
|
Child | 12 | 2022 | 80917 | 0.070 |
Why?
|
Adult | 22 | 2019 | 223646 | 0.070 |
Why?
|
Rheumatoid Factor | 1 | 2008 | 185 | 0.070 |
Why?
|
Mitochondrial Membrane Transport Proteins | 1 | 2009 | 170 | 0.070 |
Why?
|
Intestines | 1 | 2017 | 1909 | 0.070 |
Why?
|
Indicators and Reagents | 1 | 2008 | 456 | 0.070 |
Why?
|
Sensitivity and Specificity | 5 | 2017 | 14729 | 0.070 |
Why?
|
Thyroid Function Tests | 1 | 2008 | 289 | 0.070 |
Why?
|
Arousal | 1 | 2013 | 1180 | 0.070 |
Why?
|
Mass Spectrometry | 2 | 2024 | 2202 | 0.070 |
Why?
|
Brain Chemistry | 1 | 2011 | 958 | 0.070 |
Why?
|
Cross-Over Studies | 5 | 2013 | 2107 | 0.070 |
Why?
|
False Negative Reactions | 1 | 2008 | 574 | 0.070 |
Why?
|
Hepatocytes | 1 | 2014 | 1247 | 0.070 |
Why?
|
Dietary Proteins | 2 | 2013 | 960 | 0.070 |
Why?
|
Ciprofloxacin | 1 | 2009 | 313 | 0.070 |
Why?
|
Triiodothyronine | 1 | 2008 | 492 | 0.070 |
Why?
|
Bilirubin | 1 | 2008 | 438 | 0.070 |
Why?
|
Immunosuppressive Agents | 2 | 2020 | 4206 | 0.070 |
Why?
|
Neonatal Screening | 1 | 2011 | 620 | 0.070 |
Why?
|
Critical Illness | 1 | 2019 | 2756 | 0.070 |
Why?
|
Observer Variation | 1 | 2012 | 2622 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2021 | 13014 | 0.060 |
Why?
|
Female | 27 | 2024 | 397192 | 0.060 |
Why?
|
ABO Blood-Group System | 1 | 2008 | 381 | 0.060 |
Why?
|
Sheep | 1 | 2008 | 1451 | 0.060 |
Why?
|
Fat Emulsions, Intravenous | 1 | 2008 | 314 | 0.060 |
Why?
|
Fluorescence Polarization Immunoassay | 1 | 2005 | 9 | 0.060 |
Why?
|
Asthma | 2 | 2015 | 6291 | 0.060 |
Why?
|
Blood Specimen Collection | 2 | 2023 | 238 | 0.060 |
Why?
|
Heat Exhaustion | 1 | 2004 | 13 | 0.060 |
Why?
|
Triglycerides | 2 | 2011 | 2464 | 0.060 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 2008 | 1134 | 0.060 |
Why?
|
Fatigue | 1 | 2011 | 1557 | 0.060 |
Why?
|
Creatine | 1 | 2006 | 427 | 0.060 |
Why?
|
Hematopoietic Stem Cell Transplantation | 2 | 2014 | 5717 | 0.060 |
Why?
|
Renal Insufficiency | 1 | 2010 | 812 | 0.060 |
Why?
|
Young Adult | 9 | 2019 | 60066 | 0.060 |
Why?
|
Alberta | 1 | 2023 | 67 | 0.050 |
Why?
|
Child, Preschool | 6 | 2020 | 42669 | 0.050 |
Why?
|
Phenylketonurias | 1 | 2024 | 128 | 0.050 |
Why?
|
Suburban Population | 1 | 2023 | 54 | 0.050 |
Why?
|
Infant, Newborn | 4 | 2021 | 26422 | 0.050 |
Why?
|
Kidney Function Tests | 1 | 2005 | 684 | 0.050 |
Why?
|
Tanzania | 2 | 2018 | 1407 | 0.050 |
Why?
|
Poverty | 1 | 2015 | 2720 | 0.050 |
Why?
|
Paper | 1 | 2003 | 83 | 0.050 |
Why?
|
Analysis of Variance | 5 | 2013 | 6229 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2015 | 10760 | 0.050 |
Why?
|
Monitoring, Physiologic | 1 | 2010 | 1798 | 0.050 |
Why?
|
Malonates | 1 | 2022 | 43 | 0.050 |
Why?
|
Intestinal Mucosa | 1 | 2013 | 3044 | 0.050 |
Why?
|
Enzyme Stability | 2 | 2014 | 219 | 0.050 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2004 | 267 | 0.050 |
Why?
|
Physical Endurance | 1 | 2004 | 369 | 0.050 |
Why?
|
Succinates | 1 | 2022 | 83 | 0.050 |
Why?
|
Cyanides | 1 | 2022 | 82 | 0.050 |
Why?
|
Graft vs Host Disease | 1 | 2014 | 3049 | 0.050 |
Why?
|
Environmental Exposure | 1 | 2016 | 4543 | 0.050 |
Why?
|
Antidotes | 1 | 2022 | 138 | 0.050 |
Why?
|
Overweight | 1 | 2012 | 2448 | 0.050 |
Why?
|
Testosterone | 2 | 2010 | 2491 | 0.050 |
Why?
|
Denmark | 1 | 2023 | 776 | 0.040 |
Why?
|
Membrane Proteins | 1 | 2017 | 7876 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2017 | 9263 | 0.040 |
Why?
|
Time Factors | 6 | 2014 | 40218 | 0.040 |
Why?
|
Immunoglobulin G | 1 | 2012 | 4568 | 0.040 |
Why?
|
Glutarates | 1 | 2022 | 242 | 0.040 |
Why?
|
Sleep Deprivation | 1 | 2007 | 848 | 0.040 |
Why?
|
Endothelium, Vascular | 1 | 2012 | 4427 | 0.040 |
Why?
|
Recurrence | 1 | 2012 | 8509 | 0.040 |
Why?
|
Insulin | 2 | 2012 | 6607 | 0.040 |
Why?
|
Patient Readmission | 1 | 2014 | 3288 | 0.040 |
Why?
|
Stress, Physiological | 1 | 2007 | 1408 | 0.040 |
Why?
|
Cognition | 2 | 2008 | 7073 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2008 | 1596 | 0.040 |
Why?
|
Research Design | 1 | 2015 | 6211 | 0.040 |
Why?
|
Muscle, Skeletal | 3 | 2013 | 4978 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11101 | 0.040 |
Why?
|
Prospective Studies | 7 | 2024 | 54926 | 0.040 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2021 | 352 | 0.040 |
Why?
|
Regression Analysis | 2 | 2005 | 6340 | 0.040 |
Why?
|
Quality Control | 1 | 2021 | 836 | 0.040 |
Why?
|
India | 1 | 2024 | 2334 | 0.040 |
Why?
|
Luminescent Measurements | 1 | 2019 | 342 | 0.040 |
Why?
|
Blood Glucose | 2 | 2011 | 6430 | 0.040 |
Why?
|
Coronary Disease | 1 | 2012 | 5919 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2005 | 4860 | 0.040 |
Why?
|
Luminescence | 1 | 2017 | 108 | 0.040 |
Why?
|
Campylobacter | 1 | 2017 | 58 | 0.030 |
Why?
|
Enteropathogenic Escherichia coli | 1 | 2017 | 26 | 0.030 |
Why?
|
Electrochemical Techniques | 1 | 2017 | 94 | 0.030 |
Why?
|
Gastric Emptying | 1 | 2019 | 247 | 0.030 |
Why?
|
Clinical Enzyme Tests | 1 | 2016 | 114 | 0.030 |
Why?
|
Cohort Studies | 5 | 2021 | 41754 | 0.030 |
Why?
|
Powders | 1 | 2016 | 79 | 0.030 |
Why?
|
Cryptosporidium | 1 | 2017 | 43 | 0.030 |
Why?
|
Anxiety | 1 | 2011 | 4672 | 0.030 |
Why?
|
Malaysia | 1 | 2016 | 107 | 0.030 |
Why?
|
Shigella | 1 | 2017 | 69 | 0.030 |
Why?
|
Public Health | 1 | 2009 | 2679 | 0.030 |
Why?
|
Plants, Medicinal | 1 | 2016 | 167 | 0.030 |
Why?
|
Consumer Product Safety | 1 | 2016 | 122 | 0.030 |
Why?
|
Plant Leaves | 1 | 2016 | 153 | 0.030 |
Why?
|
Psychomotor Performance | 1 | 2004 | 1892 | 0.030 |
Why?
|
Hospitalization | 2 | 2015 | 10840 | 0.030 |
Why?
|
Placebos | 2 | 2012 | 1667 | 0.030 |
Why?
|
Rotavirus | 1 | 2017 | 110 | 0.030 |
Why?
|
Hazardous Substances | 1 | 2016 | 153 | 0.030 |
Why?
|
Electronic Health Records | 1 | 2013 | 4887 | 0.030 |
Why?
|
Adiponectin | 1 | 2021 | 1117 | 0.030 |
Why?
|
Liver Function Tests | 1 | 2016 | 526 | 0.030 |
Why?
|
Genome, Human | 1 | 2008 | 4446 | 0.030 |
Why?
|
Hypesthesia | 1 | 2015 | 106 | 0.030 |
Why?
|
Workflow | 1 | 2020 | 860 | 0.030 |
Why?
|
Oxides | 1 | 2016 | 403 | 0.030 |
Why?
|
Middle Aged | 7 | 2024 | 223492 | 0.030 |
Why?
|
Linear Models | 1 | 2005 | 5884 | 0.030 |
Why?
|
Phytotherapy | 1 | 2016 | 298 | 0.030 |
Why?
|
Carbon Tetrachloride | 1 | 2014 | 72 | 0.030 |
Why?
|
Toxins, Biological | 1 | 2014 | 59 | 0.030 |
Why?
|
Ubiquitination | 1 | 2019 | 1009 | 0.030 |
Why?
|
Nutritional Status | 2 | 2017 | 1628 | 0.030 |
Why?
|
Ohio | 1 | 2015 | 321 | 0.030 |
Why?
|
Zinc Sulfate | 1 | 2013 | 18 | 0.030 |
Why?
|
Syndrome | 1 | 2020 | 3272 | 0.030 |
Why?
|
Lactulose | 1 | 2013 | 32 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2018 | 1715 | 0.030 |
Why?
|
Aged | 5 | 2024 | 171504 | 0.030 |
Why?
|
Burkina Faso | 1 | 2013 | 88 | 0.030 |
Why?
|
Hydrocortisone | 2 | 2011 | 1841 | 0.030 |
Why?
|
Prostate | 1 | 2021 | 1765 | 0.030 |
Why?
|
Mannitol | 1 | 2013 | 176 | 0.030 |
Why?
|
Calcium Signaling | 1 | 2017 | 737 | 0.030 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2008 | 3729 | 0.030 |
Why?
|
Soybean Proteins | 1 | 2013 | 55 | 0.030 |
Why?
|
Erythrocytes | 2 | 2014 | 2418 | 0.030 |
Why?
|
Cyclosporine | 1 | 2015 | 777 | 0.030 |
Why?
|
Intestinal Absorption | 1 | 2013 | 400 | 0.020 |
Why?
|
Intestinal Diseases | 1 | 2017 | 505 | 0.020 |
Why?
|
Environment | 1 | 2018 | 1121 | 0.020 |
Why?
|
Body Weight | 2 | 2017 | 4627 | 0.020 |
Why?
|
Depression | 1 | 2011 | 8230 | 0.020 |
Why?
|
Prostate-Specific Antigen | 1 | 2021 | 2463 | 0.020 |
Why?
|
Absorptiometry, Photon | 2 | 2008 | 1758 | 0.020 |
Why?
|
Permeability | 1 | 2013 | 725 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2124 | 0.020 |
Why?
|
Leucine | 1 | 2013 | 547 | 0.020 |
Why?
|
Tacrolimus | 1 | 2015 | 750 | 0.020 |
Why?
|
Acetonitriles | 1 | 2011 | 55 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2024 | 22291 | 0.020 |
Why?
|
Pregnanetriol | 1 | 2010 | 4 | 0.020 |
Why?
|
17-Ketosteroids | 1 | 2010 | 36 | 0.020 |
Why?
|
Weight Gain | 1 | 2021 | 2359 | 0.020 |
Why?
|
Energy Metabolism | 3 | 2008 | 2907 | 0.020 |
Why?
|
17-alpha-Hydroxyprogesterone | 1 | 2010 | 22 | 0.020 |
Why?
|
Galactosephosphates | 1 | 2010 | 9 | 0.020 |
Why?
|
Brachial Artery | 1 | 2012 | 373 | 0.020 |
Why?
|
Mineralocorticoids | 1 | 2010 | 37 | 0.020 |
Why?
|
Androstenedione | 1 | 2010 | 132 | 0.020 |
Why?
|
Least-Squares Analysis | 1 | 2011 | 367 | 0.020 |
Why?
|
Rats, Long-Evans | 1 | 2011 | 380 | 0.020 |
Why?
|
Anti-Bacterial Agents | 1 | 2009 | 7477 | 0.020 |
Why?
|
Hemochromatosis | 1 | 2011 | 175 | 0.020 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2011 | 394 | 0.020 |
Why?
|
Feces | 1 | 2017 | 1511 | 0.020 |
Why?
|
Substrate Specificity | 1 | 2014 | 1751 | 0.020 |
Why?
|
Necrosis | 1 | 2014 | 1616 | 0.020 |
Why?
|
Hospitals | 1 | 2023 | 3886 | 0.020 |
Why?
|
Isotope Labeling | 1 | 2011 | 394 | 0.020 |
Why?
|
Organ Specificity | 1 | 2014 | 1968 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2019 | 6514 | 0.020 |
Why?
|
Glycosylation | 1 | 2012 | 1100 | 0.020 |
Why?
|
Catecholamines | 1 | 2010 | 389 | 0.020 |
Why?
|
Isoenzymes | 1 | 2014 | 1688 | 0.020 |
Why?
|
California | 1 | 2013 | 1438 | 0.020 |
Why?
|
Molecular Structure | 1 | 2013 | 1883 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 2015 | 1005 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4283 | 0.020 |
Why?
|
Yeasts | 1 | 2009 | 279 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.020 |
Why?
|
Vasodilation | 1 | 2012 | 967 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2013 | 3055 | 0.020 |
Why?
|
Dietary Carbohydrates | 1 | 2013 | 896 | 0.020 |
Why?
|
Sirolimus | 1 | 2015 | 1540 | 0.020 |
Why?
|
Phenotype | 2 | 2020 | 16726 | 0.020 |
Why?
|
Animals | 5 | 2014 | 169246 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2017 | 6082 | 0.020 |
Why?
|
Muscle Proteins | 1 | 2013 | 1165 | 0.020 |
Why?
|
Diet, Reducing | 1 | 2011 | 487 | 0.020 |
Why?
|
Physical Fitness | 1 | 2011 | 744 | 0.020 |
Why?
|
Stress, Psychological | 1 | 2003 | 4530 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2012 | 59629 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 208 | 0.020 |
Why?
|
Heme | 1 | 2009 | 316 | 0.020 |
Why?
|
Bone Development | 1 | 2010 | 473 | 0.020 |
Why?
|
Genetic Testing | 1 | 2020 | 3591 | 0.020 |
Why?
|
Solubility | 1 | 2008 | 1083 | 0.020 |
Why?
|
Aerosols | 1 | 2009 | 634 | 0.020 |
Why?
|
Muscle Fatigue | 1 | 2006 | 96 | 0.020 |
Why?
|
Pilot Projects | 1 | 2019 | 8741 | 0.020 |
Why?
|
Oxygen | 1 | 2017 | 4270 | 0.020 |
Why?
|
Fishes | 1 | 2009 | 606 | 0.020 |
Why?
|
Mice | 2 | 2014 | 82029 | 0.020 |
Why?
|
Inflammation | 2 | 2018 | 10873 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2009 | 1169 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2015 | 6316 | 0.020 |
Why?
|
Carrier State | 1 | 2009 | 529 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 4030 | 0.020 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2007 | 416 | 0.020 |
Why?
|
Pain Measurement | 1 | 2015 | 3583 | 0.020 |
Why?
|
Prealbumin | 1 | 2007 | 259 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10632 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2021 | 14783 | 0.010 |
Why?
|
Body Mass Index | 2 | 2013 | 13053 | 0.010 |
Why?
|
Mutation | 1 | 2009 | 30238 | 0.010 |
Why?
|
Random Allocation | 1 | 2009 | 2396 | 0.010 |
Why?
|
Recovery of Function | 1 | 2014 | 2981 | 0.010 |
Why?
|
United States | 4 | 2016 | 73039 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9374 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2008 | 2342 | 0.010 |
Why?
|
Oxygen Consumption | 1 | 2009 | 1880 | 0.010 |
Why?
|
Cholesterol | 1 | 2011 | 2914 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2019 | 17140 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2011 | 2403 | 0.010 |
Why?
|
Macaca mulatta | 1 | 2009 | 2363 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18412 | 0.010 |
Why?
|
Self Report | 1 | 2013 | 3773 | 0.010 |
Why?
|
Physical Exertion | 1 | 2004 | 668 | 0.010 |
Why?
|
Health Status Indicators | 1 | 2007 | 969 | 0.010 |
Why?
|
Muscle Contraction | 1 | 2006 | 1209 | 0.010 |
Why?
|
Leg | 1 | 2006 | 1088 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2010 | 2167 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 2017 | 4712 | 0.010 |
Why?
|
Androgens | 1 | 2008 | 1281 | 0.010 |
Why?
|
Lipids | 1 | 2011 | 3343 | 0.010 |
Why?
|
Anxiety Disorders | 1 | 2011 | 2748 | 0.010 |
Why?
|
Risk Factors | 2 | 2018 | 74944 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2013 | 7140 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15454 | 0.010 |
Why?
|
Adaptation, Physiological | 1 | 2007 | 1312 | 0.010 |
Why?
|
Health Promotion | 1 | 2012 | 2210 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15597 | 0.010 |
Why?
|
Risk | 1 | 2012 | 9613 | 0.010 |
Why?
|
C-Reactive Protein | 1 | 2011 | 3858 | 0.010 |
Why?
|
Fingers | 1 | 2003 | 511 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3628 | 0.010 |
Why?
|
Depressive Disorder | 1 | 2011 | 3721 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2014 | 14488 | 0.010 |
Why?
|
Women's Health | 1 | 2008 | 2082 | 0.010 |
Why?
|
Exercise Test | 1 | 2006 | 2186 | 0.010 |
Why?
|
Family | 1 | 2009 | 3209 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12543 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2018 | 39348 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2016 | 26379 | 0.010 |
Why?
|
Risk Assessment | 1 | 2016 | 24315 | 0.010 |
Why?
|
Rats | 1 | 2011 | 23760 | 0.010 |
Why?
|
Genetic Variation | 1 | 2008 | 6611 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2009 | 18349 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2008 | 16045 | 0.000 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2012 | 12252 | 0.000 |
Why?
|
Myocardial Infarction | 1 | 2008 | 11519 | 0.000 |
Why?
|
Brain | 1 | 2011 | 27360 | 0.000 |
Why?
|
Treatment Outcome | 1 | 2004 | 65371 | 0.000 |
Why?
|